| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |